Publicaciones en las que colabora con Vivian Capilla González (12)

2023

  1. Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging

    Communications Biology, Vol. 6, Núm. 1

2021

  1. Role of mesenchymal stem cells in the remodeling of the extracellular matrix in glioblastoma.

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 10

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  2. Generation of induced pluripotent stem cell (iPSC) lines from urine samples

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9

  3. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy

    Frontiers in Bioengineering and Biotechnology, Vol. 8

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Human mesenchymal stem cells prevent neurological complications of radiotherapy

    Frontiers in Cellular Neuroscience, Vol. 13

  3. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging

    Aging, Vol. 11, Núm. 18, pp. 7746-7779

2018

  1. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients

    Molecular Therapy, Vol. 26, Núm. 11, pp. 2696-2709

  2. miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation

    Molecular Therapy - Nucleic Acids, Vol. 12, pp. 463-477

2016

  1. Impact of transient down-regulation of DREAM in human embryonic stem cell pluripotency. The role of DREAM in the maintenance of hESCs.

    Stem Cell Research, Vol. 16, Núm. 3, pp. 568-578

2015

  1. Bottlenecks in the efficient use of advanced therapy medicinal products based on mesenchymal stromal cells

    Stem Cells International, Vol. 2015